A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story IV fluid expiration dates extended ...

Experts warn of continued IV fluid shortage as gray market manufacturers engage in price gouging. Baxter restarts some production after Hurricane Helene.

Baxter International cut its annual profit forecast on Friday, citing hurricane-related disruptions at its North Carolina intravenous solutions facility, causing its shares to fall 1.3% in premarket ...

Baxter, which makes around 60% of the IV solutions used in the US daily, announced that it has restarted its ...

India’s drug exporters body Pharmexcil has alerted members to a shortage of intravenous (IV) fluids that the United States is ...

After Hurricane Helene paused operations at Baxter International, the nationwide medical community has been dealing with the ...

The global peripheral intravenous catheter market is projected to experience robust growth over the next decade, with market size expected to exceed USD 13,006.1 million by 2034, up from USD 6,489.3 ...

Baxter has restarted the highest-throughput IV solutions manufacturing line at its North Cove plant in Marion, North Carolina ...

The nationwide shortage was sparked by damage to a major production facility in North Carolina from Hurricane Helene.

Baxter International plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to ...

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced the nationwide rollout of its ...